Old Articles: <Older 2141-2150 Newer> |
|
Managed Care January 2008 Peter Kongstvedt |
The Managed Care Forecast Here are some of the challenges that health insurers face this year. |
Managed Care January 2008 Thomas Kaye |
Now Is the Time for Pharmacy Performance Incentives We've made strides in increasing the transparency of pricing in the pharmacy supply chain, and now we need to change dispensing behavior. |
Managed Care January 2008 John Carroll |
Plans Look Askance at Me-Too Medications Tougher standards being applied by insurers spur debate about what constitutes true value in a new drug. |
Managed Care January 2008 Marcia Naveh |
Lax Coding by Physicians Hurts Medicare Advantage Plans By assisting doctors, insurers can get all the payment that they are due, but that too often is lost. |
Managed Care January 2008 John A. Marcille |
Higher Quality Does Mean Lower Cost at Geisinger Geisinger Health System's ProvenCare program seems to work for both sides, and if it does, there is no reason, in principle, that it cannot work with hospitals and plans that are unrelated. |
Managed Care January 2008 Michael L. Millenson |
Geisinger CABG Warranty: A Worthwhile Experiment As an idea, Geisinger's ProvenCare program is a winner. What happens in the marketplace remains to be seen. |
Managed Care January 2008 |
Copayment Rates Outpace Inflation Workers are definitely paying more for health benefits today than they were in 2000, especially for prescription drug copayments. |
Managed Care January 2008 |
American College of Physicians Promotes `Medicare for All' Plan The American College of Physicians, has endorsed single-payer national health insurance as "one pathway" to universal medical coverage. |
Managed Care January 2008 |
Too Few Programs to Manage MS? Disease management programs for patients with multiple sclerosis improve outcomes and adherence, reduce disability, and contains cost, but there are not enough of them in existence. |
Managed Care January 2008 |
Utilization Slowed by Switch From Copayment to Coinsurance Switching from a copayment benefit design to a coinsurance benefit design slowed the growth of total per-member per-month (PMPM) expenditures for all drug classes but did not have a significant effect on overall PMPM utilization. |
<Older 2141-2150 Newer> Return to current articles. |